FDA recall, , Moderate risk
LifeSouth Community Blood Centers Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced did not meet platelet yield specifications.
Recall ended Sep 25, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeSouth Community Blood Centers Inc. recalled one unit of Apheresis Platelets, Leukocytes Reduced distributed in Alabama because the platelet yield did not meet specifications. The recall began June 6, 2025, and was added to the FDA's Enforcement Report and classified on September 25, 2026. The product was included in the FDA's weekly enforcement report on October 7, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeSouth Community Blood Centers Inc
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99167
- Recall number
- B-0217-2026
- Quantity recalled
- 1 unit
All recalls from LifeSouth Community Blood Centers Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
